---
title: "Projet"
author: "Lancelot RAVIER, Jade BORDET, Sara MEKKAOUI, Manal BELOUARDA"
format:
  revealjs:
    css: assets/styles.css
    resources: images
    header-includes: |
      <script src="assets/custom.js" type="application/javascript"></script>
      <style> .no-split {page-break-inside: avoid;} </style>
---

## Outline {transition="fade" transition-speed="slow"}
- Introduction
- Presentation of the institute
- Goals of the project
    - Benefits and stakeholders
- What is epigenitics ?
- Examinating mutation 



## The institute {.smaller transition="slide" transition-speed="slow"}

![](images/labo.png){.r-stretch fig-align="center"}

* Expertise: Epigenetic mechanisms in diseases like cancer.



## Project Goal and stakeholders {.smaller transition="slide" transition-speed="slow"}

- Creating tools to improve treatment personalization and accuracy in cancer treatment
- The project will benefits both doctors and patients.

![](images/stage_of_developpment.png){.absolute left=0 width="500" height="300"}
![](images/punch.png){.absolute right=0 width="500" height="300"}




## What is Epigenetics? {.smaller transition="slide" transition-speed="slow"}

<img src="images/1.png" style="float: right">

**Gene Expression Without DNA Changes**

- Study of how genes are turned on or off without altering the DNA sequence.


---

## The diversity of cell types and functions in complex organisms {.smaller transition="slide" transition-speed="slow"}

<img src="images/2.png" style="float: right">

**Examples of Epigenetic Regulation**
 

## How epigenetics works {.smaller transition="slide" transition-speed="slow"}

<img src="images/3.png" style="float: right">


## Cancer and genes expression

![](images/epi_cancer.jpg){.r-stretch fig-align="center"}

## Cancer and genes expression
![](images/epi_cancer_2.jpg){.r-stretch fig-align="center"}


## Survival curve (Kaplan Meier)

- Represents the probability of an event, the death in our case
- Each step represents one death
- One cross represents a "censored data"

![](images/survival_curve_explaination1.png){.absolute left=0 width="400" height="400"}
![](images/survival_curve_explaination2.png){.absolute right=0 width="400" height="400"}


## Log-rank test 

- Used to compare two or more survival curves
- Only applicable if the censoring of data is independent of the "death" event and if survival curves don't cross each other

![](images/logrank_curve.png){.r-stretch fig-align="center"}

## Gene Expression Classifier (GEC)

- GEC score in our case ranges from 0 to 4

![](images/exemple_GEC_curve.png){.r-stretch fig-align="center"}

## Dataset description
- Types of available files : Gene expression levels, Bioclinical annotations of samples, GEC scores

![](images/1-dataset_secription.JPG){.r-stretch fig-align="center"}

##  Filtering Data
- Identify colon cancer-specific samples (T-Colon group).
- The initial files are not cleaned.

![](images/2-filtering_data.JPG){.r-stretch fig-align="center"}

##  Filtering Data
- Identify colon cancer-specific samples (T-Colon group).
- The initial files are not cleaned.

![](images/3-filteringdata.JPG){.r-stretch fig-align="center"}

## Survival analysis GEC 4 and 3
- Data Preparation:
- Extract data from two sources:GEC annotation file, Clinical annotation file
- Survival data limit: Set at 120 months (10 years)
- Goal: Develop a simplified prognostic test using the GEC signature for hospital use.
- A reduced 3-GEC signature is clinically feasible.
![](images/survival_curve_3GEC_GSE39582.png){.absolute right=0 width="500" height="5"}

## Survival analysis GEC 4 and 3
![](images/survival_curve_TCGA-COAD-FPKM.png){.absolute left=0 width="500" height="500"}

![](images/survival_curve_3GEC_TCGA-COAD-FPKM.png){.absolute right=0 width="500" height="500"}

## Survival analysis GEC 4 and 3
![](images/survival_curve_GSE17536.png){.absolute left=0 width="500" height="500"}

![](images/survival_curve_3GEC_GSE17536.png){.absolute right=0 width="500" height="500"}

## Survival analysis GEC 4 and 3
![](images/survival_curve_GSE39582.png){.absolute left=0 width="500" height="500"}

![](images/survival_curve_3GEC_GSE39582.png){.absolute right=0 width="500" height="500"}

## Genes mutation analyses

## Mutation data {.smaller transition="slide" transition-speed="slow"}
* Objective: Identify microsatellite instability (MSI) through mutation analysis.
<img src="images/donner_mutation.png" style="float: right">



## Distribution MSI/MSS {.smaller transition="slide" transition-speed="slow"}

<img src="images/distribution_msi_mss.png" style="float: right">

**Identify MSI samples**

## Results of cox test {.smaller transition="slide" transition-speed="slow"}

**HR and p-value**
* MSI Hazard Ratio (HR): ~0.80 (20% lower risk of death for MSI patients).
* Result not statistically significant, requiring larger sample sizes for confirmation.

![](images/resultats_test_cox_mutation.png)

## Survival curves for MSI/MSS {.smaller transition="slide" transition-speed="slow"}

<img src="images/curves_msi_mss.png" style="float: center">

## Methylation analysis for MLH1 gene


## Methylation dataset {.smaller transition="slide" transition-speed="slow"}
![](images/meth_data_1.png){.r-stretch fig-align="center"}


## MLH1 Expression dataset {.smaller transition="slide" transition-speed="slow"}
![](images/expression.png){.r-stretch fig-align="center"}


## Cleaned dataset {.smaller transition="slide" transition-speed="slow"}

![](images/final_data_meth.png){.r-stretch fig-align="center"}

## Results : {.smaller transition="slide" transition-speed="slow"}

- Significant high negative correlation, decreasing regression line
- MSI/MSS Clusters identification

![](images/meth_graph.png){.r-stretch fig-align="center"}

## Methylation of MLH1 gene {.smaller transition="slide" transition-speed="slow"}
![](images/meth_0.png)


## CNA Analysis (MSI / MSS / unknown)

- Identify MSI samples

![](images/CNA_data.png){.r-stretch fig-align="center"}

## CNA Analysis (MSI / MSS / unknown)
### Proportion MSI/MSS

- 4% of MSI / 96% of MSS/ 0% of unknowns

![](images/CNA_MSI_count.png){.r-stretch fig-align="center"}

## CNA Analysis (MSI / MSS / unknown)
### Cox Regression results

- p-value = 0.99 > 0.05

![](images/CNA_cox_results.png){.r-stretch fig-align="center"}



## MSI/MSS status for all tumor samples{.smaller}
- The promoter region of the MLH1 gene is methylated.
- A mutation occurs in one of the MLH1, MSH2, MSH6, or PMS2 genes.
- An entire DNA region containing one of these genes is lost(CNA)

![](images/MSIMSS.JPG){.r-stretch fig-align="center"}

## Team Collaboration


![](images/trello.png)
Teamwork was at the heart of our project.

we employed: 
- Python for robust data analysis.
- Lifelines for advanced survival modeling.
- Quarto to generate this presentation.


## Conclusion
